Clinical Trial Update: A Non-interventional Study to Describe the Dupilumab Long-term Treatment, Safety and Patient Reported Outcomes in Chronic Nodular Prurigo (Prurigo Nodularis) in Clinical Routine

View source ↗

Summary

An observational, non-interventional study evaluating long-term dupilumab treatment, safety, and patient-reported outcomes in chronic nodular prurigo during rou…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prurigo Nodularis

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: Sanofi | Conditions: Prurigo Nodularis | Status: RECRUITING